ARS Pharmaceuticals SPRY Earnings Call Transcripts

NASDAQ SPRY

$3.40 +0.25 (+8.10%)

As of: Nov 10, 2026 · 10:26 AM EST

4 earnings calls on file for ARS Pharmaceuticals, from Q3 2025 to Q2 2026. Each transcript opens in a new tab.

Latest earnings call

ARS Pharmaceuticals Q2 2026 Earnings Call

Aug 13, 2026 3,655 words · 16 min read

Prepared remarks and the full analyst Q&A, speaker by speaker.

Earnings calls

Calls4

LatestAug 13, 2026

SinceQ3 2025

All 4 ARS Pharmaceuticals transcripts Register to get access to ARS Pharmaceuticals’s earnings call transcripts.

ARS Pharmaceuticals

NASDAQ: SPRY

$3.40 ▲ +0.25 (+8.10%)

Nov 10, 2026 · 10:26 AM EST